Show simple item record

2015-07-06Zeitschriftenartikel DOI: 10.1371/journal.pone.0131912
Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks
dc.contributor.authorOluyinka, Opaleye O.
dc.contributor.authorTong, Hoang Van
dc.contributor.authorTien, Sy Bui
dc.contributor.authorFagbami, Ademola H.
dc.contributor.authorAdekanle, Olusegun
dc.contributor.authorOjurongbe, Olusola
dc.contributor.authorBock, Thomas
dc.contributor.authorKremsner, Peter G.
dc.contributor.authorVelavan, Thirumalaisamy P.
dc.date.accessioned2018-05-07T18:23:45Z
dc.date.available2018-05-07T18:23:45Z
dc.date.created2015-08-12
dc.date.issued2015-07-06none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/relnbcgkQaaZo/PDF/22rkmTct307N2.pdf
dc.identifier.urihttp://edoc.rki.de/176904/2110
dc.description.abstractBackground: Occult hepatitis B virus infection (OBI) characterized by the absence of detectable HBsAg remains a potential threat in blood safety. We investigated the actual prevalence, viral factors and genotype of OBI infections in Nigerian blood donors. Methods: Serum collected from two blood banks were reconfirmed as HBsAg seronegative by ELISA. Forty HBsAg positive samples were employed as controls. HBV-DNA was amplified from all donors and viral loads were determined using quantitative real-time PCR. Antibodies to the HBV core, surface and HBe antigen (anti-HBc,anti-HBs,HBeAg) were measured. The PreS/S and PreC/C regions of the HBV genome were sequenced. Results: Of the 429 blood donors, 72(17%) were confirmed as OBI by DNA detection in different reference labs and excluded the concern of possible contamination. Of the 72 OBI samples, 48(67%) were positive for anti-HBc, 25(35%) positive for anti-HBs, and 2(3%) positive for HBeAg. Of the 72 OBI samples, 31(43%) were seropositive for either anti-HBc, anti-HBs or HBeAg, 21 (30%) positive for both anti-HBc and anti-HBs,one positive for both anti-HBc and HBeAg. None of the OBI samples were positive for all three serological markers. The viral load waseng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionskrankheiten / Erreger
dc.subjectHumanseng
dc.subjectFemaleeng
dc.subjectMaleeng
dc.subjectAdulteng
dc.subjectPrevalenceeng
dc.subjectRiskeng
dc.subjectBlood Donorseng
dc.subjectBlood Safety/methodseng
dc.subjectBlood Transfusion/adverse effectseng
dc.subjectCommunicable Diseases/epidemiologyeng
dc.subjectCommunicable Diseases/immunologyeng
dc.subjectCommunicable Diseases/virologyeng
dc.subjectDNA Viral/immunologyeng
dc.subjectHepatitis B/epidemiologyeng
dc.subjectHepatitis B/immunologyeng
dc.subjectHepatitis B/transmissioneng
dc.subjectHepatitis B/virologyeng
dc.subjectHepatitis B Antibodies/immunologyeng
dc.subjectHepatitis B Core Antigens/immunologyeng
dc.subjectHepatitis B Surface Antigens/immunologyeng
dc.subjectHepatitis B e Antigens/immunologyeng
dc.subjectHepatitis B virus/immunologyeng
dc.subjectNigeriaeng
dc.subjectViral Load/immunologyeng
dc.subject.ddc610 Medizin
dc.titleOccult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10040235
dc.identifier.doi10.1371/journal.pone.0131912
dc.identifier.doihttp://dx.doi.org/10.25646/2035
local.edoc.container-titlePLoS ONE
local.edoc.container-textOluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, et al. (2015) Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS ONE 10(7): e0131912.
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131912
local.edoc.container-publisher-namePublic Library of Science
local.edoc.container-volume10
local.edoc.container-issue7
local.edoc.container-year2015

Show simple item record